Aptose Biosciences Inc. (APTO) Operating Lease, Payments USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Aptose Biosciences Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2024.
  • Aptose Biosciences Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $115 K, a 10.2% decline year-over-year.
  • Aptose Biosciences Inc. Operating Lease, Payments for the twelve months ending March 31, 2024 was $392 K, a 26.2% decline year-over-year.
  • Aptose Biosciences Inc. annual Operating Lease, Payments for 2023 was $405 K, a 25.8% decline from 2022.
  • Aptose Biosciences Inc. annual Operating Lease, Payments for 2022 was $546 K, a 1.62% decline from 2021.
  • Aptose Biosciences Inc. annual Operating Lease, Payments for 2021 was $555 K, a 3.35% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $392 K $115 K -$13 K -10.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $405 K $115 K -$20 K -14.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $425 K $117 K -$17 K -12.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $442 K $45 K -$89 K -66.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $531 K $128 K -$15 K -10.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $546 K $135 K -$1 K -0.74% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $547 K $134 K -$5 K -3.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $552 K $134 K -$6 K -4.29% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $558 K $143 K +$3 K +2.14% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $555 K $136 K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $555 K $139 K +$3 K +2.21% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $552 K $140 K +$6 K +4.48% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $546 K $140 K +$9 K +6.87% Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-02
Q4 2020 $537 K $136 K +$10 K +7.94% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 $527 K $136 K +$10 K +7.94% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $517 K $134 K +$14 K +11.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $503 K $131 K +$32 K +32.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $471 K $126 K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 $126 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $120 K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $99 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.